|
North American
Medical Advisory
Board
Dr
William J. Sandborn, Chairman
William J. Sandborn is a world expert in inflammatory
bowel disease. He has lectured extensively on
therapeutic and pharmacologic advances and has published
more than 275 peer-reviewed articles. His recent
research interests include new therapies for ulcerative
colitis and Crohn's disease.
Dr. Sandborn received his MD from Loma Linda University
School of Medicine, where he also completed a residency
in internal medicine. He then completed a fellowship in
gastroenterology at the Mayo Clinic. He is currently the
vice chair of the division of gastroenterology and
hepatology and associate director of research at the
Mayo Clinic.
Distinguished by many honours for his research efforts,
Dr. Sandborn has been the recipient of various
achievement awards. He has been elected to the
International Organization for Inflammatory Bowel
Disease and to fellowships for the American College of
Physicians, American College of Gastroenterology and
American Gastroenterological Association. Additionally,
Dr. Sandborn holds various editorial positions.
Dr
Brian Feagan
Brian Feagan is a Director of Roberts Research Institute
and a Professor of Medicine and Epidemiology and
Biostatistics at the University of Western Ontario. He
is a leading authority in inflammatoy bowel disease.
He is a specialist in Internal Medicine with training in
Clinical Epidemiology and Gastroenterology. His research
interest has been in the design and implementation of
randomized controlled trials. His most significant
research contributions relate to the findings from
several multi-centre clinical trials in which new
therapeutics for the treatment of inflammatory bowel
disease, in particular the use of immunosuppressants in
patients with Crohn’s disease, have been identified.
Dr. Feagan is also interested in the evaluation of
Health Related Quality of Life (HRQL) and has performed
research on the operating properties of HRQL
instruments. Other interests include the assessment of
health utilities in patients with Crohn’s disease and
other chronic illnesses and the application of cluster
randomization in the evaluation of health policies; a
methodology that is well-suited for the assessment of
the effectiveness of treatment programs.
Dr
Joshua A. Katz
Joshua A. Katz is an expert in Colon and Rectal surgery
and is the Director of Montgomery Colorectal Surgery
LLC. Prior to founding this practice, Dr Katz was an
assistant professor and attending surgeon at the George
Washington University Medical Center.
A double major in chemistry and biology, Dr. Katz
graduated from Yale University cum laude. He obtained
his medical degree from Cornell University Medical
College and completed a residency in general surgery at
New York University Medical Center and Bellevue Hospital
Center. He also completed a Research Fellowship at the
New York Hospital-Cornell Medical Center. He then
completed his clinical training with a Fellowship in
Colon and Rectal Surgery at Cleveland Clinic Florida,
and served an additional year as Clinical Associate for
the Department of Colorectal Surgery.
Dr. Katz’s professional memberships include the American
Society of Colon and Rectal Surgeons, the American
College of Surgeons, American Medical Association and he
also sits on the Medical Advisory Board of the Crohn’s
and Colitis Foundation.
Dr. Katz has extensive scientific publications and has
authored numerous patient information and education
packets. Dr. Katz is a frequent speaker on surgery for
inflammatory bowel diseases, colorectal cancer,
functional bowel disease and anorectal diseases.
Dr
Josh Korzenik
Josh Korzenik is a specialist in Ulcerative Colitis and
Crohn’s disease at the Massachusetts General Hospital,
is Assistant Professor of Medicine at Harvard Medical
School and is a co-director of the Crohn’s and Colitis
Centre.
Dr Korzenik obtained his medical degree from Albert
Einstein College of Medicine and completed a residency
at Beth Israel Hospital. He also completed a Fellowship
in Gasteroenterology at the Yale School of Medicine. He
is board certified in Internal Medicine and
Gastroenterology and Hepatology.
Dr Korzenik has several publications in his specialist
research interest, Crohn’s disease. His research focus
has been translational research in Inflammatory Bowel
Disease and the development of novel therapeutic agents.
Dr
Phillip B. Miner
Dr. Miner is a board-certified gastroenterologist who
joined Oklahoma Foundation for Digestive Research (OFDR)
in 1996 as President and Medical Director. He is also
Clinical Professor of Medicine at the University of
Oklahoma. Before joining OFDR, he was Professor of
Medicine and Director of the Division of
Gastroenterology at the University of Kansas for 19
years.
Dr. Miner received his medical degree from the
University of Colorado, School of Medicine. He completed
his medical internship at Kings County Hospital, State
University of New York, Downstate Medical Center, and
completed a medical residency at the Society of the New
York Hospital, Cornell University. Additional study was
conducted at the University of Colorado where he
completed a three year clinical and basic science
research fellowship in gastroenterology.
Dr. Miner received special recognition awards for his
service at the University of Kansas. He is a Fellow of
the American College of Physicians (FACP), the American
College of Gastroenterology (FACG), and American
Gastroenterological Association (AGAF). His
contributions to scientific literature include more than
135 articles, many book chapters as well as more than
200 abstracts. He lectures widely on topics related to
gastroenterology and is recognized nationally and
internationally for his expertise in Inflammatory Bowel
Disease, GERD, Irritable Bowel Syndrome, motility
disorders, pelvic floor disorders, anorectal manometry
and mast cells.
Dr
Bo Shen
Bo Shen, MD, is a world authority in the treatment of
pouchitis based within the Department of
Gastroenterology and Hepatology, at the renowned
Cleveland Clinic. His specialist interests are
pouchitis and pouch diseases, as well as inflammatory
bowel disease, GI endoscopy and imaging technology.
Dr. Shen earned his medical degree from Nantong Medical
College in Jiangsu, China. He completed internships in
internal medicine at Nantong Medical College Hospital in
China and the University of Illinois at Urbana-Champaign
in Urbana, Illinois. He also completed a fellowship in
the Department of Gastroenterology at the Cleveland
Clinic in Cleveland, Ohio.
He holds a general certification by the American Board
of Internal Medicine, as well as a specialized
certification in gastroenterology. He has secured grants
for multiple research projects including an
investigation of the clinical approach to ileal pouch
dysfunction and inflammatory bowel disease. He has also
published a number of articles in peer-reviewed journals
on gastrointestinal bleeding and irritable bowel
syndrome, among many others.
Dr. Shen is a member of the Crohn’s and Colitis
Foundation of America, the American Gastroenterological
Association, the American Society for Gastrointestinal
Endoscopy and the American College of Gastroenterology.
Dr
Steven Wexner
Steven D. Wexner, MD, is one of the world’s leading
colorectal surgeons. He is Chief Academic Officer at
Cleveland Clinic Florida, and served as Chief of Staff
for 10 years. He is also Chairman of the Department of
Colorectal Surgery, Chairman of the Division of Research
and Education, and 21st Century Oncology Chair in
Colorectal Surgery at Cleveland Clinic Florida.
Dr. Wexner holds academic appointments as Professor of
Surgery at a number of renowned Universities throughout
the world and has received 16 national, international
and regional awards for his research. He has been
awarded an FRCS from the Royal College of Surgeons in
Edinburgh, the Royal College of Surgeons in England and
been awarded the prestigious Maimonides Award.
Dr. Wexner has published over 470 manuscripts, more than
190 textbook chapters and more than 85 editorial and
invited commentaries. He is the editor or co-editor of
25 textbooks or freestanding volumes to date and is a
member of 19 editorial boards and a reviewer for an
additional 30 journals. Dr. Wexner has been elected by
his peers as one of the best colorectal surgeons for
inclusion in "The Best Doctors in America" in a host of
specialist and mainstream publications. |
